ORBIMED ADVISORS LLC – Janux Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$38.40M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+10.89%
quarter
Janux Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 3.77M | $13.54 | 2.83M | |
| Q2 2022 | share | 0.00% | 0 shares | -6.04M | $12.21 | 2.83M | |
| Q1 2022 | share | 0.00% | 0 shares | -15.28M | $14.34 | 2.83M | |
| Q4 2021 | share | Decrease | -18.17% | -630K shares | -19.01M | $19.89 | 2.83M |
| Q3 2021 | share | 0.00% | 0 shares | -11.50M | $21.63 | 3.46M | |
| Q2 2021 | share | Increase | 0.00% | 3.46M shares | 86.48M | $24.95 | 3.46M |